Global Adrenergic Agonists Sales Market Report 2016

Publisher Name :
Date: 09-Sep-2016
No. of pages: 124
Inquire Before Buying

Notes:

Sales, means the sales volume of Adrenergic Agonists

Revenue, means the sales value of Adrenergic Agonists

This report studies sales (consumption) of Adrenergic Agonists in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

- Alpha

- Par Sterile Products, LLC

- Dentsply Pharmaceutical

- Merck Sharp & Dohme Corp.

- Sanofi/Synthelabo Inc

- GSK

- Hujefa Vora, MD

- ...

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Adrenergic Agonists in these regions, from 2011 to 2021 (forecast), like

- USA

- China

- Europe

- Japan

- India

- Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Adrenergic Agonists in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Adrenergic Agonists Sales Market Report 2016

Table of Contents
Global Adrenergic Agonists Sales Market Report 2016
1 Adrenergic Agonists Overview
1.1 Product Overview and Scope of Adrenergic Agonists
1.2 Classification of Adrenergic Agonists
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Adrenergic Agonists
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Adrenergic Agonists Market by Regions
1.4.1 USA Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Adrenergic Agonists (2011-2021)
1.5.1 Global Adrenergic Agonists Sales and Growth Rate (2011-2021)
1.5.2 Global Adrenergic Agonists Revenue and Growth Rate (2011-2021)
2 Global Adrenergic Agonists Competition by Manufacturers, Type and Application
2.1 Global Adrenergic Agonists Market Competition by Manufacturers
2.1.1 Global Adrenergic Agonists Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Adrenergic Agonists Revenue and Share by Manufacturers (2011-2016)
2.2 Global Adrenergic Agonists (Volume and Value) by Type
2.2.1 Global Adrenergic Agonists Sales and Market Share by Type (2011-2016)
2.2.2 Global Adrenergic Agonists Revenue and Market Share by Type (2011-2016)
2.3 Global Adrenergic Agonists (Volume and Value) by Regions
2.3.1 Global Adrenergic Agonists Sales and Market Share by Regions (2011-2016)
2.3.2 Global Adrenergic Agonists Revenue and Market Share by Regions (2011-2016)
2.4 Global Adrenergic Agonists (Volume) by Application
3 USA Adrenergic Agonists (Volume, Value and Sales Price)
3.1 USA Adrenergic Agonists Sales and Value (2011-2016)
3.1.1 USA Adrenergic Agonists Sales and Growth Rate (2011-2016)
3.1.2 USA Adrenergic Agonists Revenue and Growth Rate (2011-2016)
3.1.3 USA Adrenergic Agonists Sales Price Trend (2011-2016)
3.2 USA Adrenergic Agonists Sales and Market Share by Manufacturers
3.3 USA Adrenergic Agonists Sales and Market Share by Type
3.4 USA Adrenergic Agonists Sales and Market Share by Application
4 China Adrenergic Agonists (Volume, Value and Sales Price)
4.1 China Adrenergic Agonists Sales and Value (2011-2016)
4.1.1 China Adrenergic Agonists Sales and Growth Rate (2011-2016)
4.1.2 China Adrenergic Agonists Revenue and Growth Rate (2011-2016)
4.1.3 China Adrenergic Agonists Sales Price Trend (2011-2016)
4.2 China Adrenergic Agonists Sales and Market Share by Manufacturers
4.3 China Adrenergic Agonists Sales and Market Share by Type
4.4 China Adrenergic Agonists Sales and Market Share by Application
5 Europe Adrenergic Agonists (Volume, Value and Sales Price)
5.1 Europe Adrenergic Agonists Sales and Value (2011-2016)
5.1.1 Europe Adrenergic Agonists Sales and Growth Rate (2011-2016)
5.1.2 Europe Adrenergic Agonists Revenue and Growth Rate (2011-2016)
5.1.3 Europe Adrenergic Agonists Sales Price Trend (2011-2016)
5.2 Europe Adrenergic Agonists Sales and Market Share by Manufacturers
5.3 Europe Adrenergic Agonists Sales and Market Share by Type
5.4 Europe Adrenergic Agonists Sales and Market Share by Application
6 Japan Adrenergic Agonists (Volume, Value and Sales Price)
6.1 Japan Adrenergic Agonists Sales and Value (2011-2016)
6.1.1 Japan Adrenergic Agonists Sales and Growth Rate (2011-2016)
6.1.2 Japan Adrenergic Agonists Revenue and Growth Rate (2011-2016)
6.1.3 Japan Adrenergic Agonists Sales Price Trend (2011-2016)
6.2 Japan Adrenergic Agonists Sales and Market Share by Manufacturers
6.3 Japan Adrenergic Agonists Sales and Market Share by Type
6.4 Japan Adrenergic Agonists Sales and Market Share by Application
7 India Adrenergic Agonists (Volume, Value and Sales Price)
7.1 India Adrenergic Agonists Sales and Value (2011-2016)
7.1.1 India Adrenergic Agonists Sales and Growth Rate (2011-2016)
7.1.2 India Adrenergic Agonists Revenue and Growth Rate (2011-2016)
7.1.3 India Adrenergic Agonists Sales Price Trend (2011-2016)
7.2 India Adrenergic Agonists Sales and Market Share by Manufacturers
7.3 India Adrenergic Agonists Sales and Market Share by Type
7.4 India Adrenergic Agonists Sales and Market Share by Application
8 Southeast Asia Adrenergic Agonists (Volume, Value and Sales Price)
8.1 Southeast Asia Adrenergic Agonists Sales and Value (2011-2016)
8.1.1 Southeast Asia Adrenergic Agonists Sales and Growth Rate (2011-2016)
8.1.2 Southeast Asia Adrenergic Agonists Revenue and Growth Rate (2011-2016)
8.1.3 Southeast Asia Adrenergic Agonists Sales Price Trend (2011-2016)
8.2 Southeast Asia Adrenergic Agonists Sales and Market Share by Manufacturers
8.3 Southeast Asia Adrenergic Agonists Sales and Market Share by Type
8.4 Southeast Asia Adrenergic Agonists Sales and Market Share by Application
9 Global Adrenergic Agonists Manufacturers Analysis
9.1 Alpha
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Adrenergic Agonists Product Type, Application and Specification
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 Alpha Adrenergic Agonists Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Par Sterile Products, LLC
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 124 Product Type, Application and Specification
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 Par Sterile Products, LLC Adrenergic Agonists Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 Dentsply Pharmaceutical
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 146 Product Type, Application and Specification
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 Dentsply Pharmaceutical Adrenergic Agonists Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 Merck Sharp & Dohme Corp.
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Sept Product Type, Application and Specification
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 Merck Sharp & Dohme Corp. Adrenergic Agonists Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Sanofi/Synthelabo Inc
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Product Type, Application and Specification
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 Sanofi/Synthelabo Inc Adrenergic Agonists Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 GSK
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Million USD Product Type, Application and Specification
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 GSK Adrenergic Agonists Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 Hujefa Vora, MD
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharmaceuticals Product Type, Application and Specification
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 Hujefa Vora, MD Adrenergic Agonists Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
10 Adrenergic Agonists Maufacturing Cost Analysis
10.1 Adrenergic Agonists Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Adrenergic Agonists
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Adrenergic Agonists Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Adrenergic Agonists Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Adrenergic Agonists Market Forecast (2016-2021)
14.1 Global Adrenergic Agonists Sales, Revenue Forecast (2016-2021)
14.2 Global Adrenergic Agonists Sales Forecast by Regions (2016-2021)
14.3 Global Adrenergic Agonists Sales Forecast by Type (2016-2021)
14.4 Global Adrenergic Agonists Sales Forecast by Application (2016-2021)
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Adrenergic Agonists
Table Classification of Adrenergic Agonists
Figure Global Sales Market Share of Adrenergic Agonists by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Adrenergic Agonists
Figure Global Sales Market Share of Adrenergic Agonists by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Adrenergic Agonists Revenue and Growth Rate (2011-2021)
Figure China Adrenergic Agonists Revenue and Growth Rate (2011-2021)
Figure Europe Adrenergic Agonists Revenue and Growth Rate (2011-2021)
Figure Japan Adrenergic Agonists Revenue and Growth Rate (2011-2021)
Figure India Adrenergic Agonists Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Adrenergic Agonists Revenue and Growth Rate (2011-2021)
Figure Global Adrenergic Agonists Sales and Growth Rate (2011-2021)
Figure Global Adrenergic Agonists Revenue and Growth Rate (2011-2021)
Table Global Adrenergic Agonists Sales of Key Manufacturers (2011-2016)
Table Global Adrenergic Agonists Sales Share by Manufacturers (2011-2016)
Figure 2015 Adrenergic Agonists Sales Share by Manufacturers
Figure 2016 Adrenergic Agonists Sales Share by Manufacturers
Table Global Adrenergic Agonists Revenue by Manufacturers (2011-2016)
Table Global Adrenergic Agonists Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Adrenergic Agonists Revenue Share by Manufacturers
Table 2016 Global Adrenergic Agonists Revenue Share by Manufacturers
Table Global Adrenergic Agonists Sales and Market Share by Type (2011-2016)
Table Global Adrenergic Agonists Sales Share by Type (2011-2016)
Figure Sales Market Share of Adrenergic Agonists by Type (2011-2016)
Figure Global Adrenergic Agonists Sales Growth Rate by Type (2011-2016)
Table Global Adrenergic Agonists Revenue and Market Share by Type (2011-2016)
Table Global Adrenergic Agonists Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Adrenergic Agonists by Type (2011-2016)
Figure Global Adrenergic Agonists Revenue Growth Rate by Type (2011-2016)
Table Global Adrenergic Agonists Sales and Market Share by Regions (2011-2016)
Table Global Adrenergic Agonists Sales Share by Regions (2011-2016)
Figure Sales Market Share of Adrenergic Agonists by Regions (2011-2016)
Figure Global Adrenergic Agonists Sales Growth Rate by Regions (2011-2016)
Table Global Adrenergic Agonists Revenue and Market Share by Regions (2011-2016)
Table Global Adrenergic Agonists Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Adrenergic Agonists by Regions (2011-2016)
Figure Global Adrenergic Agonists Revenue Growth Rate by Regions (2011-2016)
Table Global Adrenergic Agonists Sales and Market Share by Application (2011-2016)
Table Global Adrenergic Agonists Sales Share by Application (2011-2016)
Figure Sales Market Share of Adrenergic Agonists by Application (2011-2016)
Figure Global Adrenergic Agonists Sales Growth Rate by Application (2011-2016)
Figure USA Adrenergic Agonists Sales and Growth Rate (2011-2016)
Figure USA Adrenergic Agonists Revenue and Growth Rate (2011-2016)
Figure USA Adrenergic Agonists Sales Price Trend (2011-2016)
Table USA Adrenergic Agonists Sales by Manufacturers (2011-2016)
Table USA Adrenergic Agonists Market Share by Manufacturers (2011-2016)
Table USA Adrenergic Agonists Sales by Type (2011-2016)
Table USA Adrenergic Agonists Market Share by Type (2011-2016)
Table USA Adrenergic Agonists Sales by Application (2011-2016)
Table USA Adrenergic Agonists Market Share by Application (2011-2016)
Figure China Adrenergic Agonists Sales and Growth Rate (2011-2016)
Figure China Adrenergic Agonists Revenue and Growth Rate (2011-2016)
Figure China Adrenergic Agonists Sales Price Trend (2011-2016)
Table China Adrenergic Agonists Sales by Manufacturers (2011-2016)
Table China Adrenergic Agonists Market Share by Manufacturers (2011-2016)
Table China Adrenergic Agonists Sales by Type (2011-2016)
Table China Adrenergic Agonists Market Share by Type (2011-2016)
Table China Adrenergic Agonists Sales by Application (2011-2016)
Table China Adrenergic Agonists Market Share by Application (2011-2016)
Figure Europe Adrenergic Agonists Sales and Growth Rate (2011-2016)
Figure Europe Adrenergic Agonists Revenue and Growth Rate (2011-2016)
Figure Europe Adrenergic Agonists Sales Price Trend (2011-2016)
Table Europe Adrenergic Agonists Sales by Manufacturers (2011-2016)
Table Europe Adrenergic Agonists Market Share by Manufacturers (2011-2016)
Table Europe Adrenergic Agonists Sales by Type (2011-2016)
Table Europe Adrenergic Agonists Market Share by Type (2011-2016)
Table Europe Adrenergic Agonists Sales by Application (2011-2016)
Table Europe Adrenergic Agonists Market Share by Application (2011-2016)
Figure Japan Adrenergic Agonists Sales and Growth Rate (2011-2016)
Figure Japan Adrenergic Agonists Revenue and Growth Rate (2011-2016)
Figure Japan Adrenergic Agonists Sales Price Trend (2011-2016)
Table Japan Adrenergic Agonists Sales by Manufacturers (2011-2016)
Table Japan Adrenergic Agonists Market Share by Manufacturers (2011-2016)
Table Japan Adrenergic Agonists Sales by Type (2011-2016)
Table Japan Adrenergic Agonists Market Share by Type (2011-2016)
Table Japan Adrenergic Agonists Sales by Application (2011-2016)
Table Japan Adrenergic Agonists Market Share by Application (2011-2016)
Figure India Adrenergic Agonists Sales and Growth Rate (2011-2016)
Figure India Adrenergic Agonists Revenue and Growth Rate (2011-2016)
Figure India Adrenergic Agonists Sales Price Trend (2011-2016)
Table India Adrenergic Agonists Sales by Manufacturers (2011-2016)
Table India Adrenergic Agonists Market Share by Manufacturers (2011-2016)
Table India Adrenergic Agonists Sales by Type (2011-2016)
Table India Adrenergic Agonists Market Share by Type (2011-2016)
Table India Adrenergic Agonists Sales by Application (2011-2016)
Table India Adrenergic Agonists Market Share by Application (2011-2016)
Figure Southeast Asia Adrenergic Agonists Sales and Growth Rate (2011-2016)
Figure Southeast Asia Adrenergic Agonists Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Adrenergic Agonists Sales Price Trend (2011-2016)
Table Southeast Asia Adrenergic Agonists Sales by Manufacturers (2011-2016)
Table Southeast Asia Adrenergic Agonists Market Share by Manufacturers (2011-2016)
Table Southeast Asia Adrenergic Agonists Sales by Type (2011-2016)
Table Southeast Asia Adrenergic Agonists Market Share by Type (2011-2016)
Table Southeast Asia Adrenergic Agonists Sales by Application (2011-2016)
Table Southeast Asia Adrenergic Agonists Market Share by Application (2011-2016)
Table Alpha Basic Information List
Table Alpha Adrenergic Agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alpha Adrenergic Agonists Global Market Share (2011-2016)
Table Par Sterile Products, LLC Basic Information List
Table Par Sterile Products, LLC Adrenergic Agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Par Sterile Products, LLC Adrenergic Agonists Global Market Share (2011-2016)
Table Dentsply Pharmaceutical Basic Information List
Table Dentsply Pharmaceutical Adrenergic Agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dentsply Pharmaceutical Adrenergic Agonists Global Market Share (2011-2016)
Table Merck Sharp & Dohme Corp. Basic Information List
Table Merck Sharp & Dohme Corp. Adrenergic Agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Sharp & Dohme Corp. Adrenergic Agonists Global Market Share (2011-2016)
Table Sanofi/Synthelabo Inc Basic Information List
Table Sanofi/Synthelabo Inc Adrenergic Agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi/Synthelabo Inc Adrenergic Agonists Global Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Adrenergic Agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Adrenergic Agonists Global Market Share (2011-2016)
Table Hujefa Vora, MD Basic Information List
Table Hujefa Vora, MD Adrenergic Agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hujefa Vora, MD Adrenergic Agonists Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adrenergic Agonists
Figure Manufacturing Process Analysis of Adrenergic Agonists
Figure Adrenergic Agonists Industrial Chain Analysis
Table Raw Materials Sources of Adrenergic Agonists Major Manufacturers in 2015
Table Major Buyers of Adrenergic Agonists
Table Distributors/Traders List
Figure Global Adrenergic Agonists Sales and Growth Rate Forecast (2016-2021)
Figure Global Adrenergic Agonists Revenue and Growth Rate Forecast (2016-2021)
Table Global Adrenergic Agonists Sales Forecast by Regions (2016-2021)
Table Global Adrenergic Agonists Sales Forecast by Type (2016-2021)
Table Global Adrenergic Agonists Sales Forecast by Application (2016-2021)
  • C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 72
    C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2017 Summary C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) pipeline Target constitutes close to 15 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2017, outlays comprehensive info......
  • C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 59
    C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2017 Summary C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - CXCR2 or Interleukin 8 receptor, beta is a chemokine receptor. It binds to IL8 with high affinity, and transduces the signal through a G-prot......
  • C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 54
    C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017 Summary C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) pipeline Target constitutes close to 7 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes. The latest report C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017, outlays comprehensive information on the C5a Anaphylato......
  • Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 53
    Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2017 Summary Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Prostaglandin D2 (PGD2) receptors are G protein-coupled receptors that binds and is activated by prostaglandin D2. ......
  • Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 45
    Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017 Summary According to the recently published report 'Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H2 2017'; Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. ......
  • Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 74
    Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2017 Summary Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) pipeline Target constitutes close to 17 molecules. Out of which approximately 17 molecules are developed by Companies. The lat......
  • Glucagon Like Peptide 2 Receptor (GLP2R) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 49
    Glucagon Like Peptide 2 Receptor (GLP2R) - Pipeline Review, H2 2017 Summary Glucagon Like Peptide 2 Receptor (GLP2R) - Glucagon-like peptide 2 receptor (GLP-2R) is a protein encoded by the GLP2R gene. GLP2R, a G protein-coupled receptor superfamily member is expressed in the gut. GLP2 stimulates intestinal growth and up regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. GLP2 prevent......
  • Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 55
    Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017 Summary According to the recently published report 'Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017'; Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) pipeline Target constitutes close to 14 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes. M......
  • Restenosis - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 48
    Restenosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis - Pipeline Review, H2 2017, provides an overview of the Restenosis (Cardiovascular) pipeline landscape. Restenosis is re-narrowing of a blood vessel which leads to restricted blood flow. Symptoms include shortness of breath, difficulty walking and chest pain. Risk factors include increasing age, gender, family hist......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs